City
Epaper

Pinworm medication may treat aggressive skin cancer: Researchers

By IANS | Updated: April 20, 2025 11:22 IST

New York, April 20 A team of US scientists has found that a common pinworm medication may stop ...

Open in App

New York, April 20 A team of US scientists has found that a common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer.

The research led by University of Arizona Cancer Center and published in the Journal of Clinical Investigation, found that in laboratory models of Merkel cell carcinoma, pyrvinium pamoate inhibited cancer cell growth and reversed the cancer’s neuroendocrine features.

In mouse models of Merkel cell carcinoma, pyrvinium pamoate reduced tumour growth.

Merkel cell carcinoma is a rare but fast-growing neuroendocrine cancer that is three to five times more likely than melanoma to be deadly. Response rates to current therapies – surgery, radiation and immunotherapy – are limited, resulting in a need for effective and broadly applicable therapeutics.

“Merkel cell carcinoma is increasing in incidence. Even though it’s a rare cancer type, it mimics a lot of properties that other cancers have,” said senior author Megha Padi, assistant professor at the university.

Pyrvinium pamoate, a medication approved by the Food and Drug Administration in 1955 to treat pinworms, has been shown to have antitumour potential in several different cancers, including breast, colorectal, pancreatic and bladder cancers. This is the first time it has been studied in models of Merkel cell carcinoma.

Padi and the research team found that in laboratory models of Merkel cell carcinoma, pyrvinium pamoate inhibited cancer cell growth and reversed the cancer’s neuroendocrine features. In mouse models of Merkel cell carcinoma, pyrvinium pamoate reduced tumor growth.

“This is a hypothesis, but some people think the reason an antiparasitic agent could be effective against cancers is because tumours are a little bit like parasites in our body,” Padi said. “Parasites and tumours must develop ways to use scarce resources in their host to feed themselves and allow for unlimited multiplication. If the pathways that they have hijacked to feed themselves are the same, then you get lucky, and you have a tumour type that could be amenable to killing by these antiparasitic drugs.”

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentCharlotte Kirk to star in crime drama series 'Write To Kill'

NationalCong stands with SS-UBT in the fight to protect 'Maharashtra Dharma': Harshwardhan Sapkal

TechnologyMizoram govt to expand digital services for public benefit, smart governance: CM Lalduhoma

InternationalUS lawmakers introduce bill to formalise 'six assurances' amid rising tensions with China

Other SportsWankhede is even more iconic now," says SKY on unveiling of Rohit Sharma stand

Health Realted Stories

HealthWith 2.5 lakh participants, Vizag Yoga Day event to create world record

HealthOver 295 mn people across 53 countries faced acute hunger in 2024: UN 

HealthSilent killer ‘hypertension’ affecting over 294 mn people in SE Asia: WHO

HealthDengue fever cases surge in Southern Vietnam

HealthPSLV to mark 63rd launch with Earth Observation Satellite-09 on May 18: ISRO Chairman